Navigation Links
Genta in Medical News

New Report Just Published: World Multiple Myeloma Therapeutics Market Report

...nces, Inc., Celgene Corporation, F. Hoffmann-La Roche Ltd, Genentech, Inc., genta Incorporated, Millennium Pharmaceuticals, Ortho Biotech Products, LP, Seatt...ffmann-La Roche Ltd (Switzerland) II-56 Genentech, Inc. (USA) II-56 genta Incorporated (USA) II-56 Millennium Pharmaceuticals (USA) II-57 Ort...

FDA Accepts Genta's NDA Amendment as Complete Response for Genasense(R) Treatment of Chronic Lymphocytic Leukemia

...the effectiveness of current anticancer treatment. genta is pursuing a broad clinical development program w... to treat various forms of cancer. About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...

Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel

...ultidrug-resistant p-glycoprotein. About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...g statements with respect to business conducted by genta Incorporated. By their nature, forward-looking sta...

Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors

...ars of counsel and service to our Company." About genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients for a global Phas...

Genta to Present at Bio Investor Forum 2007 Conference

...l be archived at the website for two weeks. About genta genta Incorporated is a biopharmaceutical company with a...ated hypercalcemia that is resistant to hydration. genta is partnered with IDIS (http://www.idispharma.com...

Mighty Conqueror Felled by Stomach Cancer

... reached the liver. Lead study author, Robert genta of University of Texas Southwestern genta and his colleagues compared the description of the...nd that the emperor’s lesions were cancerous. genta says,” It was a huge mass from the entrance of his...
Genta in Medical Technology

Genta Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma

...the effectiveness of current anticancer treatment. genta is pursuing a broad clinical development program w... to treat various forms of cancer. About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...

FDA Lifts Clinical Hold on Genta's Tesetaxel, a Leading Oral Taxane

...the lifting of this clinical hold. About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...g statements with respect to business conducted by genta Incorporated. By their nature, forward-looking sta...

Genasense(R) Chemotherapy Program Yields High Response Rate in Patients with Stage 4 Melanoma

...the effectiveness of current anticancer treatment. genta is pursuing a broad clinical development program w... to treat various forms of cancer. About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...

Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders

...the effectiveness of current anticancer treatment. genta is pursuing a broad clinical development program w... to treat various forms of cancer. About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...

Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology

... Advanced Melanoma. (Publication). About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...g statements with respect to business conducted by genta Incorporated. By their nature, forward-looking sta...

Genta Receives Key Patent Related to Oral Gallium Compound G4544

... BERKELEY HEIGHTS, N.J., April 14 /PRNewswire/ -- genta Incorporated (Nasdaq: GNTA ) today announced that...ion. Ganite is exclusively marketed in the U.S. by genta and is available to patients outside the U.S. on a "named-patient" basis. About Genta genta Incorporated is a biopharmaceutical company with a...

Specialized Genasense(R) Clinical Trials Featured at AACR Meeting

...the effectiveness of current anticancer treatment. genta is pursuing a broad clinical development program w... to treat various forms of cancer. About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...

DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma

...tent/abstract/JCO.2006.06.0483v1 . About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...g statements with respect to business conducted by genta Incorporated. By their nature, forward-looking sta...

FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data

... decision issued in response to an appeal filed by genta in October 2007, CDER acknowledged that complete r...h collection and analysis of existing data in CLL, genta has developed a new clinical trial, and the Compan...ical Oncology (25:1114, 2007). Conference Call genta management will further discuss the current status...

Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights

...ir development." Highlights and updates of the genta programs appear below. Genasense: Clinical and R...y Phase 3/Melanoma: In the third quarter of 2007, genta initiated a confirmatory, Phase 3, randomized, con...ed either alone or in combination with a taxane. genta has now completed clinical trials to evaluate inte...
Genta in Biological News

Napoleon's mysterious death unmasked, UT Southwestern researcher says

...th has been highly scrutinized over the years. Dr. genta and his colleagues, whose research focuses on gast...rs of arsenic poisoning. To find answers, Dr. genta and the other researchers combined current medical... Gastric cancer was more likely at fault, Dr. genta said. Other scholars have recently found that the ...
Genta in Biological Technology

Auditors for Genta Incorporated Express Going Concern Qualification

BERKELEY HEIGHTS, N.J., March 20 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA ) announced today that in its 2007 financial statements included in the Company's Annual Report on Form 10-K, the auditor's opinion contained a "going concern" qualification. NASDAQ's marketplace rules...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...oscapine to be Effective in Prostate Cancer II-55 Fosamax(R) Found Effective in Preventing Bone Loss in Prostate Cancer Patients II-55 genta Unveils Results of Phase II Clinical Trial of Genasense(R) in Prostate Cancer II-55 Cell Therapeutics Reveals Phase 2 Clinical Trial Results o...

Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma

...f 300 patients are expected to enroll in AGENDA. genta will provide a pooled update of blinded data from ...the effectiveness of current anticancer treatment. genta is pursuing a broad clinical development program w... to treat various forms of cancer. About Genta genta Incorporated is a biopharmaceutical company with a...

Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights

...and partnering opportunities." Highlights of the genta programs appear below. Genasense: The Leading An...g in Clinical Development Genasense in Melanoma: genta is currently enrolling patients with advanced mela...nticancer Activity In other regulatory activity, genta submitted its response to a prior notice from FDA ...

Genta Announces Second Quarter 2008 Financial Results and Conference Call

...008 financial results on Thursday, August 7, 2008. genta management will host a conference call and live au...ternational). The access code for the live call is genta Incorporated. The call will also be webcast live a... conference ID number is 57549066. About Genta genta Incorporated is a biopharmaceutical company with a...

Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane

...nts that have already issued in the United States. genta holds worldwide exclusive licenses to these patent...the lifting of this clinical hold. About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...

Genta Submits NDA Amendment to FDA for Genasense as Treatment of Chronic Lymphocytic Leukemia

...cology (ASCO) in Chicago on Monday June 2, 2008. genta was notified in March 2008 that its appeal of a "n...the effectiveness of current anticancer treatment. genta is pursuing a broad clinical development program w... to treat various forms of cancer. About Genta genta Incorporated is a biopharmaceutical company with a...

Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs

...y's option, and will be convertible into shares of genta common stock at a conversion rate of 100,000 share...ding days. Certain members of senior management of genta Incorporated participated in this offering. The No...on from registration requirements. About Genta genta Incorporated is a biopharmaceutical company with a...

Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights

... CLL -- Company restructures to conserve cash -- genta will seek buyer for Ganite and terminates c-myb an...ir development." Highlights and updates of the genta programs appear below. Genasense: The Leading A...ug in Clinical Development Genasense in Melanoma: genta is currently enrolling patients with advanced mela...

Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results

...luation of strategic options. The Company will provide updates as more information emerges. Emisphere has six product candidates in Phase I: -- genta Incorporated began a Phase I clinical study of oral gallium in the third quarter of 2007; -- A research partner has conducted Phase I studies of ...
Genta in Biological Dictionary

Antisense

... of antisense ESTs are depicted in white. ... Antisense custom design and synthesis for specific gene silencing, using superior results. ... genta Obtains Orphan Drug Designation for C-Myb Antisense ... We have evaluated the specificity and the variation in activity against human immunod...
Other Tags
(Date:8/21/2014)... Black mothers are less likely than white moms to ... Hospitals in neighborhoods with many black residents do less ... white residents, a U.S. government study finds. Key ... medical centers where the black population is higher than ... and Prevention reported Thursday. These practices include efforts ...
(Date:8/21/2014)... 21, 2014 The W. Montague ... and a national voice in the elimination of ... disparities during the 112th National Medical Association’s (NMA) ... included: , John Ruffin, Ph.D, former Director of ... Disparities, whose life-long career and innovations have had ...
(Date:8/21/2014)... physicians in rural communities do not routinely screen ... Penn State medical and public health researchers. Rural ... limited resources if they seek help., "Rural health ... said Jennifer S. McCall-Hosenfeld, a primary care physician ... sciences, Penn State College of Medicine. "However, in ...
(Date:8/21/2014)... The report "Industrial Flue Gas Treatment Systems & ... Particulate Control, Mercury Control) by Application (Power Generation, ... Global Trends & Forecasts to 2019" defines and ... & services market with analysis and projection of ... The industrial flue gas treatment systems & services ...
(Date:8/21/2014)... STOCKHOLM, SWEDEN (PRWEB) August 21, 2014 ... today that this year's conference will focus on ... be expected for research, innovation and commercialization. , ... successful ventures, SALSS combines the worlds' of business ... to a widely recognized Summit, gathering a diverse ...
Breaking Medicine News(10 mins):Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2Health News:W. Montague Cobb/NMA Health Institute Honors Three Outstanding Leaders in Health Disparities 2Health News:Primary care physicians can be critical resource for abused women in rural areas 2Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 2Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 3Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 4Health News:The Tenth Swedish-American Life Science Summit, takingplace in Stockholm, Sweden, August 20-22nd, will focus on The Future of Medicine 2
(Date:8/20/2014)... -  Issue Serious allergic reactions to ... threatening for some children.    What you should ... food allergies and this number may be increasing, especially among ... to have food allergies.  The symptoms of ... to breathing difficulties and loss of consciousness. Symptoms can also ...
(Date:8/20/2014)... outcomes of approximately 3 million infants, a team of ... University of Massachusetts Medical School, have shown that newborn ... implemented across public health newborn screening programs. Data from ... issue of the Journal of the American Medical ... SCID in newborns is higher than previously thought and ...
(Date:8/20/2014)... scientists have discovered that acral melanomas the rare type ... are genetically distinct from other more common types of ... in the journal Pigment Cell & Melanoma Research . ... hands, soles of the feet, nail-beds and other hairless parts ... it,s not caused by UV damage from the sun. , ...
Breaking Biology News(10 mins):Information Update - Allergens and food safety at school - What's in your child's lunch? 2Information Update - Allergens and food safety at school - What's in your child's lunch? 3Newborn screening expansion offers early diagnosis and treatment to infants with SCID 2Newborn screening expansion offers early diagnosis and treatment to infants with SCID 3Scientists learn more about rare skin cancer that killed Bob Marley 2
Other Contents